Benjamin R. Bashline, DO

Article

Vemurafenib-Induced Plantar Hyperkeratosis

Author:: Benjamin R. Bashline, DO

Publish date: September 27, 2018

Vemurafenib, a selective BRAF inhibitor, is a chemotherapeutic agent used in the treatment of metastatic melanoma with BRAF mutations. It has been ...